Your browser doesn't support javascript.
loading
Factors Impacting Survival in Those Transplanted for NASH Cirrhosis: Data From the NailNASH Consortium.
Rinella, Mary E; Satapathy, Sanjaya K; Brandman, Danielle; Smith, Coleman; Elwir, Sal; Xia, Jonathan; Gibson, Meg; Figueredo, Carlos; Angirekula, Mounika; Vanatta, Jason M; Sarwar, Raiya; Jiang, Yu; Gregory, Dyanna; Agostini, Tandy; Ko, JimIn; Podila, Pradeep; Gallo, Grace; Watt, Kymberly D; Siddiqui, Mohammad S.
Afiliación
  • Rinella ME; Pritzker School of Medicine, University of Chicago, Chicago, Illinois; Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: mrinella@bsd.uchicago.edu.
  • Satapathy SK; Division of Hepatology at Sandra Atlas Bass Center for Liver Diseases & Transplantation, Barbara and Zucker School of Medicine/Northwell Health, Manhasset, New York.
  • Brandman D; University of California San Francisco, San Francisco, California.
  • Smith C; MedStar Georgetown Transplant Institute, Washington, District of Columbia.
  • Elwir S; Baylor University Medical Center, Dallas, Texas.
  • Xia J; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Gibson M; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Figueredo C; Department of Gastroenterology and Hepatology, Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York.
  • Angirekula M; Mayo Clinic, Rochester, Minnesota.
  • Vanatta JM; University of Tennessee/Methodist University Hospital, Memphis, Tennessee.
  • Sarwar R; Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, Minnesota.
  • Jiang Y; University of Tennessee/Methodist University Hospital, Memphis, Tennessee.
  • Gregory D; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Agostini T; MedStar Georgetown Transplant Institute, Washington, District of Columbia.
  • Ko J; MedStar Georgetown Transplant Institute, Washington, District of Columbia.
  • Podila P; Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Gallo G; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Watt KD; Mayo Clinic, Rochester, Minnesota.
  • Siddiqui MS; Virginia Commonwealth University, Richmond, Virginia.
Clin Gastroenterol Hepatol ; 21(2): 445-455.e2, 2023 02.
Article en En | MEDLINE | ID: mdl-35189388
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Diabetes Mellitus Tipo 2 / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Guideline / Prognostic_studies Límite: Aged / Female / Humans Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Diabetes Mellitus Tipo 2 / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Guideline / Prognostic_studies Límite: Aged / Female / Humans Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos